
    
      The number of patient is thirthy-six.Patients were randomly assigned either anplag
      tablet(Sarpogrelate HCL 100mg, tid)3days first, DP-R202(Sarpogrelate HCL 300mg, qd) 3days
      Second or DP-R202(Sarpogrelate HCL 300mg, qd)3days first, anplag tablet(Sarpogrelate HCL
      100mg, tid) 3days second.
    
  